Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

Purpose Lenalidomide maintenance therapy after autologous stem-cell transplantation (ASCT) demonstrated prolonged progression-free survival (PFS) versus placebo or observation in several randomized controlled trials (RCTs) of patients with newly diagnosed multiple myeloma (NDMM). All studies had PFS...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology Jg. 35; H. 29; S. 3279
Hauptverfasser:	McCarthy, Philip L, Holstein, Sarah A, Petrucci, Maria Teresa, Richardson, Paul G, Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C, Caillot, Denis, Gay, Francesca, Moreau, Philippe, Marit, Gerald, Jung, Sin-Ho, Yu, Zhinuan, Winograd, Benjamin, Knight, Robert D, Palumbo, Antonio, Attal, Michel
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 10.10.2017
Schlagworte:	Adult Aged Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - adverse effects Chemotherapy, Adjuvant Disease Progression Disease-Free Survival Drug Administration Schedule Female Humans Kaplan-Meier Estimate Lenalidomide Maintenance Chemotherapy Male Middle Aged Multiple Myeloma - diagnosis Multiple Myeloma - mortality Multiple Myeloma - therapy Randomized Controlled Trials as Topic Risk Factors Stem Cell Transplantation - adverse effects Stem Cell Transplantation - mortality Thalidomide - administration & dosage Thalidomide - adverse effects Thalidomide - analogs & derivatives Time Factors Transplantation, Autologous Treatment Outcome Young Adult
ISSN:	1527-7755, 1527-7755
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!